Inhibition of left ventricular fibrosis by tranilast in rats with renovascular hypertension
Authors:
- Berthold HocherBHBerthold Hocher
- Michael GodesMGMichael Godes
- Jan OlivierJOJan Olivier
- Joachim WeilJWJoachim Weil
- Thomas EschenhagenTEThomas Eschenhagen
- Torsten SlowinskiTSTorsten Slowinski
- Hans-H. NeumayerHNHans-H. Neumayer
- Christian BauerCBChristian Bauer
- Martin PaulMPMartin Paul
- Yigal M. PintoYPYigal M. Pinto
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 20 (4) , 745-751
Abstract
Growth factors such as transforming growth factor-beta (TGFβ) are believed to have an essential role in cardiac fibrosis. Tranilast (N (3,4-dimethoxycinnamoyl) anthranilic acid) attenuates the increased expression of TGFβ mRNA in vitro. To investigate whether tranilast reduces cardiac fibrosis in rats with two-kidney, one-clip (2K1C) renovascular hypertension. In addition, we tested the in-vitro effects of tranilast on cardiac myocytes and non-myocyte cells. We analysed hearts from four groups of rats: sham-operated controls; rats with 2K1C renovascular hypertension; rats with 2K1C renovascular hypertension treated for 12 weeks with the angiotensin converting enzyme (ACE) inhibitor, quinapril (6 mg/kg per day); rats with 2K1C renovascular hypertension treated for 12 weeks with tranilast (400 mg/kg per day). Systolic blood pressure was reduced after quinapril treatment. Tranilast did not alter blood pressure (2K1C: 223 ± 19 mmHg; 2K1C + quinapril: 149 ± 15 mmHg (P < 0.01 compared with 2K1C); 2K1C + tranilast: 204 ± 32 mmHg). Left ventricular weight was likewise reduced significantly by quinapril, but not significantly by tranilast (2K1C: 1.52 ± 0.2 g; 2K1C + quinapril: 1.26 ± 0.18 g (P < 0.05 compared with 2K1C); 2K1C + tranilast: 1.37 ± 0.27 g). Using a computer-aided image analysis system, we demonstrated that tranilast prevented cardiac fibrosis in a blood-pressure-independent manner (P < 0.01 compared with 2K1C). Determination of the cardiac hydroxyproline content similarly revealed a significant reduction in cardiac fibrosis by tranilast (2K1C: 4.92 ± 0.48 mg/mg; 2K1C + tranilast: 3.97 ± 0.46 mg/mg;P < 0.05). The effect of tranilast on cardiac fibrosis was comparable to the effects of a blood-pressure-decreasing dose of the ACE inhibitor, quinapril. Cell culture experiments revealed that tranilast significantly decreased the proliferation of cardiac non-myocyte cells. Proliferation of cardiac myocytes was not altered. This study revealed that long-term treatment with tranilast markedly attenuated left ventricular fibrosis in rats with renovascular hypertension. This was most probably the result of an antiproliferative effect of tranilast on cardiac non-myocyte cells. Tranilast thus offers a unique new therapeutic approach to the reduction of TGFβ-mediated cardiac fibrosis in vivo.Keywords
This publication has 29 references indexed in Scilit:
- Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor β 1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 RatHypertension, 2000
- Identification of Tranilast-Binding Protein as 36-kDa Microfibril-Associated Glycoprotein by Drug Affinity Chromatography, and Its Localization in Human SkinBiochemical and Biophysical Research Communications, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Endothelin System–Dependent Cardiac Remodeling in Renovascular HypertensionHypertension, 1999
- Hypertension-Induced End-Organ DamageHypertension, 1999
- Differential Protein Expression and Subcellular Distribution of TGFβ1,β2andβ3in Cardiomyocytes During Pressure Overload-induced HypertrophyJournal of Molecular and Cellular Cardiology, 1997
- Inhibitory Effect of Tranilast on Activation and Transforming Growth Factor β1 Expression in Cultured Rat Stellate CellsBiochemical and Biophysical Research Communications, 1996
- Myocardial Remodeling in Hypertensive Ren-2 Transgenic RatsHypertension, 1995
- Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes anf functions of fibroblasts in vitroLife Sciences, 1994
- The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillationAmerican Heart Journal, 1977